Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57. / Bak, Mads; Boonen, Susanne E; Dahl, Christina; Hahnemann, Johanne M D; Mackay, Deborah J D G; Tümer, Zeynep; Grønskov, Karen; Temple, I Karen; Guldberg, Per; Tommerup, Niels.

I: BMC Medical Genetics, Bind 17, 29, 14.04.2016.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bak, M, Boonen, SE, Dahl, C, Hahnemann, JMD, Mackay, DJDG, Tümer, Z, Grønskov, K, Temple, IK, Guldberg, P & Tommerup, N 2016, 'Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57', BMC Medical Genetics, bind 17, 29. https://doi.org/10.1186/s12881-016-0292-4

APA

Bak, M., Boonen, S. E., Dahl, C., Hahnemann, J. M. D., Mackay, D. J. D. G., Tümer, Z., ... Tommerup, N. (2016). Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57. BMC Medical Genetics, 17, [29]. https://doi.org/10.1186/s12881-016-0292-4

Vancouver

Bak M, Boonen SE, Dahl C, Hahnemann JMD, Mackay DJDG, Tümer Z o.a. Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57. BMC Medical Genetics. 2016 apr 14;17. 29. https://doi.org/10.1186/s12881-016-0292-4

Author

Bak, Mads ; Boonen, Susanne E ; Dahl, Christina ; Hahnemann, Johanne M D ; Mackay, Deborah J D G ; Tümer, Zeynep ; Grønskov, Karen ; Temple, I Karen ; Guldberg, Per ; Tommerup, Niels. / Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57. I: BMC Medical Genetics. 2016 ; Bind 17.

Bibtex

@article{b5de3df3b1f043348558331ee39e8e8a,
title = "Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57",
abstract = "BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers.METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing.RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif.CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease.",
author = "Mads Bak and Boonen, {Susanne E} and Christina Dahl and Hahnemann, {Johanne M D} and Mackay, {Deborah J D G} and Zeynep T{\"u}mer and Karen Gr{\o}nskov and Temple, {I Karen} and Per Guldberg and Niels Tommerup",
year = "2016",
month = "4",
day = "14",
doi = "10.1186/s12881-016-0292-4",
language = "English",
volume = "17",
journal = "B M C Medical Genetics",
issn = "1471-2350",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57

AU - Bak, Mads

AU - Boonen, Susanne E

AU - Dahl, Christina

AU - Hahnemann, Johanne M D

AU - Mackay, Deborah J D G

AU - Tümer, Zeynep

AU - Grønskov, Karen

AU - Temple, I Karen

AU - Guldberg, Per

AU - Tommerup, Niels

PY - 2016/4/14

Y1 - 2016/4/14

N2 - BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers.METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing.RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif.CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease.

AB - BACKGROUND: Transient neonatal diabetes mellitus 1 (TNDM1) is a rare imprinting disorder characterized by intrautering growth retardation and diabetes mellitus usually presenting within the first six weeks of life and resolves by the age of 18 months. However, patients have an increased risk of developing diabetes mellitus type 2 later in life. Transient neonatal diabetes mellitus 1 is caused by overexpression of the maternally imprinted genes PLAGL1 and HYMAI on chromosome 6q24. One of the mechanisms leading to overexpression of the locus is hypomethylation of the maternal allele of PLAGL1 and HYMAI. A subset of patients with maternal hypomethylation at PLAGL1 have hypomethylation at additional imprinted loci throughout the genome, including GRB10, ZIM2 (PEG3), MEST (PEG1), KCNQ1OT1 and NESPAS (GNAS-AS1). About half of the TNDM1 patients carry mutations in ZFP57, a transcription factor involved in establishment and maintenance of methylation of imprinted loci. Our objective was to investigate whether additional regions are aberrantly methylated in ZFP57 mutation carriers.METHODS: Genome-wide DNA methylation analysis was performed on four individuals with homozygous or compound heterozygous ZFP57 mutations, three relatives with heterozygous ZFP57 mutations and five controls. Methylation status of selected regions showing aberrant methylation in the patients was verified using bisulfite-sequencing.RESULTS: We found large variability among the patients concerning the number and identity of the differentially methylated regions, but more than 60 regions were aberrantly methylated in two or more patients and a novel region within PPP1R13L was found to be hypomethylated in all the patients. The hypomethylated regions in common between the patients are enriched for the ZFP57 DNA binding motif.CONCLUSIONS: We have expanded the epimutational spectrum of TNDM1 associated with ZFP57 mutations and found one novel region within PPP1R13L which is hypomethylated in all TNDM1 patients included in this study. Functional studies of the locus might provide further insight into the etiology of the disease.

U2 - 10.1186/s12881-016-0292-4

DO - 10.1186/s12881-016-0292-4

M3 - Journal article

VL - 17

JO - B M C Medical Genetics

JF - B M C Medical Genetics

SN - 1471-2350

M1 - 29

ER -

ID: 161086036